Full-Time

Product Support Specialist

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Peterborough, UK + 4 more

More locations: Lakenheath, UK | Essex, UK | Norwich, UK | Bedford, UK

In Person

Willingness to travel up to 80% across field-based roles.

Category
Customer Experience & Support (1)

Get referred to Stryker

See people who can refer or advise you

Requirements
  • Excellent communication skills with proficiency in spoken and written English.
  • Outgoing and persuasive manner and ability to deal with people who hold differing beliefs or values.
  • Confidence and persistence.
  • Patience and self-motivation.
  • Analytical and planning skills.
  • Flexible approach to work to adapt to changes.
  • Strong teamwork and networking skills.
  • Commercial and business awareness.
  • Valid driving license.
  • Ability and self-confidence to meet the customer on an equal footing to discuss medical and economic issues
  • Sales Skills – challenge the customer
  • Assertiveness
  • Service and solution oriented
  • OR experience
  • Learning skills – Ability to apply new skills at any time. Is open to new ideas.
  • Self-employment: High self-organization skills
  • Willingness to travel
  • Positive attitude, a "can do" solution orientated approach to succeed.
  • Self-motivated, you take ownership of your work
  • Collaborative partners, you build and leverage relationships to bring together ideas, data and insights to drive continuous improvements and ultimately to secure wins within your own team as well as in other teams/functions across the business.
  • Teamwork is an integral part of this role.
  • Goal Orientated, to thrive in this fast-paced environment you will stop at nothing to ensure you achieve your goals, keeping the patient/customer and their requirements squarely in focus, we want people who deliver safe and robust solutions.
  • High Ethics & Integrity, we want you to win in the right way, that’s a fundamental building block of Stryker’s vision of being the most admired company in healthcare.
Responsibilities
  • Stryker Citizen always Demonstrates outstanding ethics. Treats customers and employees with respect, represents the company in the best possible light.
  • Knowledge: Communicates essential benefits of products and their clinical applications.
  • Customer Service: Acts with integrity and reactively delivers on commitments within the required timescales.
  • Business Planning: Constructs a basic business plan with input from mentor/manager. Daily, weekly, and monthly planning decided in partnership with mentor and RSM.
  • Sales Skills: Develops rapport. Understands the importance of relationships in selling. Using open questioning techniques to ascertain customer's needs and has good working knowledge of key brands to open opportunities for the sales team to sell. Uses customer troubleshooting opportunities to grow and protect the business.
  • Commercial Awareness: Understands that there are multiple stakeholders in the decision-making process and asks appropriate questions to identify the stakeholders.
  • Discretion/Latitude/Impact: Work is closely supervised, and specific direction provided by more experienced staff. Keeps supervisor informed regularly on status of work. Failure to achieve results can normally be overcome without serious effect on revenue or budget.
  • Achieve sales results in line with the annual sales target and KPI metrics
  • Planning, prioritizing, and executing of required activities and customer support.
  • Segmentation of the sales area and define a focus on the expansion of existing customers, as well as support for growing customers together with the Sales Team
  • Support/maintenance of existing customers to maintain customer satisfaction/quality and collaboration with the Sales Team and other departments.
  • Development of short and medium-term strategies in collaboration with the customer to secure/strengthen the Stryker position.
  • Good communication and negotiation on an equal footing with customers, using reasonable and appropriate methods to ensure a profitable and sustainable relationship
  • Market observations to strengthen own position and constant analysis of responsible area
  • Address challenges with the customer and develop solutions (with support of RSM/Sales Team)
  • Participate in in-house meetings to discuss organizational, development, and business issues and enhance relevant knowledge and skills
  • Administration of IT based customer database/CRM-Tool
  • Clinical/Technical Expertise: Serve as front-line clinical and technical support to surgeons and hospital staff before, during and after surgical procedures.
  • Train and guide surgeons and hospital staff in the use of Stryker’s Mako robot including set-up, breakdown and related intra-operative activities to ensure precise and successful surgical outcomes.
  • Use proprietary software to prepare pre-operative CT scans for assigned cases and assist surgeons in pre-operative implant planning, implant sizing and positioning.
  • Troubleshoot and solve technical issues related to the robot independently or field escalation matters appropriately.
  • Partner with Field Service team effectively to ensure technical issues are resolved and maintenance is delivered.
  • Build knowledge of Stryker implants and instrumentation and mastery of the robot and its different applications in order to become a trusted “go-to” for all case coverage types (robotic and manual).
  • Educate surgeons and staff on the clinical benefits of the robot and best practices with confidence, enthusiasm and respect.
  • Complete Mako 101 and 201 training for all robotic-assisted surgery applications. Obtain certification for each application needed to perform independent case coverage.
  • Complete JR 101 and 201 training and develop an understanding of all basic manual procedures.
  • Develop ability to competently cover complex primary and revision hip and knee procedures.

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 organic sales rose 9%, with strong MedSurg and Orthopaedics growth.
  • AVS closed in Q2 2026, expanding peripheral vascular exposure and salesforce leverage.
  • Management raised 2026 outlook to 8.3%-9.3% organic growth and $14.95-$15.10 EPS.

What critics are saying

  • March 2026 cyberattack disrupted manufacturing, delayed shipments, and exposed operational fragility.
  • Peripheral vascular supply disruption created Q2 2026 backorders, with recovery targeted only by Q3.
  • Any repeat cyber incident or plant outage would hit revenue and threaten 2026 guidance.

What makes Stryker unique

  • Mako robotics keeps winning installations and supports Stryker's orthopedic workflow lock-in.
  • Stryker spans MedSurg, Neurotechnology, and Orthopaedics, cushioning demand across procedure types.
  • Pangea Plating and TPX HD show a steady, surgeon-led product launch cadence.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 2nd, 2026
Stryker shares drop 6.4% after Q2 earnings as analysts see 23% upside to $386.80 fair value

Stryker shares fell 6.42% following its second-quarter 2026 earnings release, which showed sales of $6.59 billion and net income of $1.28 billion. The medical technology company is now trading approximately 23% below one valuation estimate and 18% beneath the average analyst target. Analysts currently place Stryker's fair value at $386.80, compared to its recent closing price of $325.70. Price targets vary significantly amongst analysts, ranging from $315 to $465. The year-to-date share price return has fallen 6.46%, though the company maintains a five-year total shareholder return of 30.66%. Potential risks to the company's outlook include prolonged EU regulatory delays and sustained supply chain disruptions that could affect product launches and margins.

Yahoo Finance
Aug 1st, 2026
Stryker meets Q2 revenue expectations at $6.59B but supply chain woes dampen growth outlook

Stryker reported Q2 revenue of $6.59 billion, up 9.4% year on year, meeting Wall Street expectations. The medical technology company's non-GAAP earnings of $3.69 per share beat analyst estimates by 5.8%. Despite meeting forecasts, investors reacted negatively due to supply chain disruptions in the peripheral vascular business. Chief executive Kevin Lobo said the quarter focused on recovery from a recent cybersecurity incident, which caused production disruptions and elevated backlogs. The company expects backorders to normalise by the end of Q3. Management cited strong demand for capital equipment and Mako robotics, which saw record Q2 installations. Operating margin expanded to 25.2% from 18.5% last year, supported by operational discipline and efficiency initiatives. Management slightly raised full-year adjusted earnings guidance.

Yahoo Finance
Jul 31st, 2026
Stryker reports 9% organic sales growth in Q2 2026 despite cybersecurity impact

Stryker reported strong second-quarter 2026 results with 9% organic sales growth, driven by high single-digit gains in both its med surg and neurotechnology and orthopaedics businesses. The medical device company is recovering from a cybersecurity incident whilst ramping up production to meet demand. In the US, Stryker achieved 9% organic sales growth, with double-digit expansion in its medical, trauma extremities, and endoscopy divisions. The company's OrthoTech and instruments segments posted high single-digit growth. However, supply disruptions affected the peripheral vascular business, creating a significant backorder situation and lost sales. Stryker expects to resolve these issues by the end of the third quarter. The company also completed its acquisition of AVS during the quarter and remains confident in the long-term outlook for its peripheral vascular business.

Yahoo Finance
Jul 30th, 2026
Stryker reports $6.6B Q2 sales, up 9.4%, as company recovers from cyber incident

Stryker Corporation reported second quarter 2026 results, with net sales rising 9.4% to $6.6 billion and organic sales up 9.0%. The medical technology company's adjusted earnings per share increased 17.9% to $3.69, whilst reported EPS jumped 44.1% to $3.30. The company's MedSurg and Neurotechnology division posted sales of $3.6 billion, up 9.7%, with organic growth of 9.2%. Orthopaedics sales reached $3.0 billion, increasing 9.1%. Chair and CEO Kevin Lobo attributed the strong performance to recovery from a cyber incident, noting the company's resilience. Adjusted operating margin improved 170 basis points to 27.4%. Stryker expressed confidence in maintaining growth at the high end of the medical technology sector for the second half of 2026.

Yahoo Finance
Jul 1st, 2026
Stryker's joint-replacement moat edges Intuitive's premium valuation despite Q1 cyberattack

Stryker reported $6.02 billion in revenue for Q1 2026, missing the $6.33 billion consensus following a March cyberattack, whilst Intuitive Surgical beat expectations with $2.77 billion in revenue, up 23%, and earnings per share of $2.50 against a $2.11 consensus. Despite the cyberattack impact, Stryker's core businesses remained strong, with its Mako-driven orthopaedics franchise growing and its Vascular division jumping 27.5% following the Inari acquisition. The company maintained full-year guidance of 8% to 9.5% organic growth and delivered free cash flow of $415 million, up 227%. Stryker trades at approximately 22 times forward earnings compared to Intuitive Surgical's 39 times, as da Vinci procedure growth guidance steps down from 18% to roughly 15%.